Skip to content

Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy With EEG Extended With Intra-auricular Electrodes

Evaluation of the Use of Video EEG Examination Extended With Intra-auricular Electrodes in the Assessment of Patients With Drug-resistant Temporal Lobe Epilepsy

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06366009
Enrollment
30
Registered
2024-04-15
Start date
2024-04-08
Completion date
2024-07-31
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Resistant Epilepsy, Epilepsy, Focal Epilepsy

Keywords

in-ear EEG, EEG, epilepsy, focal epilepsy, drug resistant epilepsy, intra-auricular EEG

Brief summary

The study aims to evaluate the effectiveness of long-term video EEG monitoring using 10-20 electrodes extended with intra-auricular electrodes in locating the seizure onset zone and interictal epileptiform discharges (IEDs) in patients with temporal lobe epilepsy (TLE) and nontemporal lobe epilepsy (non-TLE).

Detailed description

This study is a monocentric observational study aiming to evaluate the effectiveness of long-term video EEG monitoring using 10-20 electrodes extended with intra-auricular electrodes in locating the seizure onset zone and interictal epileptiform discharges (IEDs) in patients with temporal lobe epilepsy (TLE) and nontemporal lobe epilepsy (non-TLE). 30 subjects with drug-resistant focal epilepsy undergoing long-term EEG monitoring as part of the pre-surgical assessment will be included. All patients referred to the UCK WUM Department of Neurosurgery for video EEG monitoring will be subject to prescreening. Those who, according to prior medical documentation, don't meet exclusion criteria and are likely to meet inclusion criteria will be invited to participate in the study and will undergo an initial assessment in form of a structured interview with a clinician, EEG recordings will be carried out simultaneously using standard EEG equipment (full set of electrodes according to the 10-20 system extended by additional temporal electrodes T9/T10) and the NAOX in-ear EEG system device. EEG monitoring will take place for 5 days of hospitalization according to the standard protocol of the Video-EEG Laboratory of the Department of Neurosurgery, CSK UCK, Medical.

Interventions

DEVICENaoX in-ear EEG system

EEG recordings will be carried out simultaneously using standard EEG equipment (full set of electrodes according to the 10-20 system extended by additional temporal electrodes T9/T10) and the NAOX in-ear EEG system device.

Sponsors

NaoX Technologies
CollaboratorINDUSTRY
Warsaw Medical University Clinical Center
CollaboratorUNKNOWN
Departments and Clinics of Emergency Medicine of the Medical University of Gdańsk
CollaboratorUNKNOWN
Przemyslaw Kunert
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Diagnosis of drug-resistant epilepsy * Sufficient level of cooperation to use of the NAOX in-ear EEG system * Providing informed consent to participate in the study

Exclusion criteria

* Presence of skull bone defects, e.g. after prior neurosurgery * Presence of comorbidities that may significantly affect the resting EEG * Medical history strongly suggestive of psychogenic nonepileptic attacks

Design outcomes

Primary

MeasureTime frameDescription
determination of the starting point of focal temporal epileptic seizuresDay 5correlation of the seizure onset zone encompassing intra-auricular electrodes with the clinically determined location of the focus within the medial temporal lobe

Secondary

MeasureTime frameDescription
Identification of subgroups of epileptic patternsDay 5Identification of subgroups of epileptic patterns which, depending on the location of the epileptic focus may be more clearly visible at intra-auricular sites than in standard 10-20 system electrode locations, may be visible exclusively at intra-auricular locations, may not be visible at intra-auricular location
Assessment of ease-of-use and comfort of use of the NAOX in-ear EEG system by patients and the EEG technicianDays 1-5Questionnaire to EEG technician and patient

Countries

Poland

Contacts

Primary ContactPrzemysław Kunert, Prof.
przemyslaw.kunert@uckwum.pl0048 22 599 1575
Backup ContactMaja Kopytek-Beuzen, Dr.
maja.beuzen@uckwum.pl0048 22 599 2575

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026